Gráfico del Precio de Acciones PPBT
PPBT Ganando
Purple Biotech Ltd
$4.12
5.49%
$0.21
Al cierre: May 08, 16:00:00 GMT-4
$3.95
-4.24%
$-0.17
Mercado Posterior: May 08, 20:00:00 GMT-4
Atrás
Purple Biotech Ltd (PPBT) Ganando
Estadísticas clave
Cierre Anterior
$3.91
Precio de apertura
$4.08
Rango del día
$3.95 - $4.19
Rango de 52 semanas
$3.6 - $29
Volumen
3.3K
Volumen promedio
13.3K
Rendimiento de dividendos
--
EPS (TTM)
-54.00
Cap. de mercado
$3.6M
¿Qué es Purple Biotech Ltd.?
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Características
© 2026 Edgen impulsado por